The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.
Open accessAbstract
BACKGROUND: Heavy alcohol consumption, viral hepatitis, and diabetes are risk factors for hepatocellular carcinoma (HCC). However, to the authors' knowledge, the information concerning their interaction effect in patients with risk of HCC is sparse. METHODS: A population‐based, case–control study of HCC was conducted during 1984–2002. The study involved 295 HCC cases and 435 age‐, gender‐, and race‐matched control subjects among Hispanic and non‐Hispanic whites and blacks in Los Angeles County, California. Lifestyle risk factors were ascertained through in‐person interviews. Infections with the hepatitis B and C (HCV) viruses were determined using their serologic markers. RESULTS: Fourteen HCC cases but no control subjects tested positive for the hepatitis B surface antigen. Seropositivity for antibodies to HCV was associated with an odds ratio (OR) of 125 (95% confidence interval [95% CI], 17–909) for HCC, whereas seropositivity for antibodies to the hepatitis B core antigen was related to an OR of 2.9 (95% CI, 1.7–5.0). Heavy alcohol consumption and cigarette smoking were found to be independently associated with a statistically significant two to threefold increase in risk of HCC after adjustment for hepatitis B and C serology. Subjects with a history of diabetes had an OR of 2.7 (95% CI, 1.6–4.3) for HCC compared with nondiabetic subjects. A synergistic interaction on HCC risk was observed between heavy alcohol consumption and diabetes (OR = 4.2; 95% CI, 2.6–5.8), heavy alcohol consumption and viral hepatitis (OR = 5.5; 95% CI, 3.9–7.0), or between diabetes and viral hepatitis (OR = 4.8; 95% CI, 2.7–6.9). CONCLUSIONS: Heavy alcohol consumption, diabetes, and viral hepatitis were found to exert independent and synergistic effects on risk of HCC in U.S. blacks and whites. Cancer 2004. © 2004 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
Frankel, E. N., German, J. B., Kinsella, J. E., Parks, E., & Kanner, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90206-v · Cited by 1,647
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Fuhrman, B., Lavy, A., & Aviram, M. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.549 · Cited by 675
Ikeda, K., Saitoh, S., Suzuki, Y., Kobayashi, M., Tsubota, A., Koida, I., Arase, Y., Fukuda, M., Chayama, K., Murashima, N., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80339-5 · Cited by 428
Reid, A. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.27126 · Cited by 394
THE ESTIMATION OF SYNERGY OR ANTAGONISM1
ROTHMAN, K. J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112252 · Cited by 333
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
Yeh, F.-S., Yu, M. C., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1990) · Health Policy · doi:10.1016/0168-8510(90)90389-u · Cited by 324
Self-citationBruun, J., Verdich, C., Toubro, S., Astrup, A., & Richelsen, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480535 · Cited by 295
The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El-Serag, H. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02617-x · Cited by 274
ZAMAN, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91785-4 · Cited by 257
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh, F. S., Yuan, J., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1989) · PubMed · Cited by 201
Self-citationYu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Self-citationLower risk for alcohol-induced cirrhosis in wine drinkers
Becker, U., Grønbæk, M., Johansen, D., & Sørensen, T. I. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32101 · Cited by 185
Epidemiology of Hepatocellular Carcinoma
Yu, M. C., Yuan, J.-M., Govindarajan, S., & Ross, R. K. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/371801 · Cited by 179
Self-citationYu, M. C., Tong, M. J., Coursaget, P., Ross, R. K., Govindarajan, S., & Henderson, B. E. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1038 · Cited by 175
Self-citationWang, L., You, S., Lu, S., Ho, H. C., Wu, M. H., Sun, C. A., Yang, H., & Chen, C. (2003) · Cancer Causes & Control · doi:10.1023/a:1023636619477 · Cited by 157
Hassan, M. M., Frome, A., Patt, Y. Z., et al. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200209000-00013 · Cited by 130
Chen, Z., Liu, B., Boreham, J., Wu, Y., Chen, J., & Peto, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11342 · Cited by 107
Diabetes mellitus in chronic active hepatitis and cirrhosis
Kingston, M. E., Ali, M. A., Atiyeh, M., & Donnelly, R. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90544-4 · Cited by 96
Roizen, R., Kerr, W. C., & Fillmore, K. M. (1999) · BMJ · doi:10.1136/bmj.319.7211.666 · Cited by 87
Yu, M. C., Yuan, J., Ross, R. K., & Govindarajan, S. (1997) · Hepatology · doi:10.1002/hep.510250141 · Cited by 72
Self-citationIncidence of altered glucose tolerance in liver cirrhosis
Gentile, S., Loguercio, C., Marmo, R., Carbone, L., & Blanco, C. D. V. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90130-w · Cited by 59
Free Radical Formation in Livers of Rats Treated Acutely and Chronically with Alcohol
Reinke, L. A., Moore, D. R., & McCay, P. B. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03816.x · Cited by 40
Is necroinflammation a prerequisite for fibrogenesis?
Cp, D. (1996) · PubMed · Cited by 35
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
Metadata
- Authors
- Yuan, J., Govindarajan, S., Arakawa, K., & Yu, M. C.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-08-18
- Volume
- 101
- Issue
- 5
- Pages
- 1009-1017
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2046215345
- Cited by
- 275
- References
- 40
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.